Grifols
Grifols, IBL International to Develop Specialty Diagnostics
IBL will develop biomarker panels for use with Grifols' random-access, single-molecule counting platform, and the firms will collaborate on testing workflows.
Grifols Secures $21M MJFF Grant to Search for Early Parkinson's Biomarkers
Grifols subsidiary Alkahest will lead a pilot study to track proteomic changes in patient plasma samples over a 10-year period.
Grifols Obtains CE Mark for Multiplex Molecular Arbovirus Screening Test
The Procleix ArboPlex test detects chikungunya, dengue, West Nile, and Zika viruses in a single-tube reaction using a fully automated nucleic acid amplification system.
In a bid to expand recognition and treatment of alpha-1 antitrypsin deficiency, a cause of COPD, Grifols is making its over-the-counter genetic test available for free.
FDA Clears Grifols AAT Deficiency Test, OraSure Saliva Collection Device for Over-the-Counter Use
The test screens for genetic mutations commonly associated with the condition and can now be used with OraSure Technologies' ORAcollect Dx collection device.